LEVETIRACETAM DEXCEL 500

Land: Israël

Taal: Engels

Bron: Ministry of Health

Werkstoffen:

LEVETIRACETAM

Beschikbaar vanaf:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-code:

N03AX14

farmaceutische vorm:

TABLETS

Samenstelling:

LEVETIRACETAM 500 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

DEXCEL LTD, ISRAEL

Therapeutische categorie:

LEVETIRACETAM

Therapeutisch gebied:

LEVETIRACETAM

therapeutische indicaties:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Autorisatie datum:

2018-03-31